Author

hubert marotte 1

1 university of saint etienne

: THERAPEUTIC DRUG MONITORING OF INFLIXIMAB AND MUCOSAL HEALING IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY

Stéphane Paul, hubert marotte, Emilie Del Tedesco, Laurent Peyrin-Biroulet, Xavier Roblin

AZATHIOPRINE DOSE REDUCTION  INFLAMMATORY BOWEL DISEASE PATIENTS ON COMBINATION THERAPY: A PROSPECTIVE STUDY

Emilie Del Tedesco, Stéphane Paul, hubert marotte, Nicolas Williet, Jean Marc Phelip, Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Xavier Roblin

PERSISTENCE OF ANTIBODIES TO INFLIXIMAB FOR MORE THAN TWO MONTHS STRONGLY PREDICTS LOSS OF RESPONSE TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASES

manon leclerc, Stéphane Paul, hubert marotte, Emilie Del Tedesco, Laurent Biroulet, Xavier Roblin

RESIDUAL ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH CLINICAL REMISSION AND MUCOSAL HEALING IN IBD.

Xavier Roblin, Melanie Rinaudo, hubert marotte, Emilie Del Tedesco, Jean Marc Phelip, Laurent Peyrin-Biroulet, Stéphane Paul

Item 1 - 4 / 4
1